Zurueck zur Suche

Reporte zur Charge U039948

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

14Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
VA 4 CA 3 FL 2 MI 2 NM 1 UT 1 IL 1

VAERS 2415949

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039948

moderat
Staat
CA
Alter
4,0
Geschlecht
F
Eingang
19.08.2022
Impfdatum
18.08.2022
Beginn
18.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Body temperature increased Chest X-ray normal Dyspnoea Enterovirus test positive Human rhinovirus test positive

Symptomtext

Patient presented to ED about 5 hours after vaccine with shortness of breath and temperature 100.4

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
CXR normal, nasal swab positive for rhinovirus/enterovirus
Aktuelle Erkrankungen
none
Vorgeschichte
congenital atrial septal defect
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2630841

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039948

mild
Staat
NM
Alter
1,3
Geschlecht
U
Eingang
11.05.2023
Impfdatum
18.04.2023
Beginn
30.04.2023
Tage bis Beginn
12,0
Dosis
2
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cough Ear infection Pyrexia Rash Rash erythematous Respiratory tract congestion

Symptomtext

16 month-old here with mother for follow-up on ear infection. Had completed antibiotics x 10 days and no issues at this time. (+) MMR, varicella - given on 4/19/2023 4 days ago, had fever x 2 days and then on third day, had erythematous rash that started on the face and spread to the trunk and extremities. (+) cough and congestion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
3/10/23 R Bacterial conjunctivitis
Vorgeschichte
None
Andere Medikamente
N/A
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2568690

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039948

mild
Staat
CA
Alter
1,2
Geschlecht
F
Eingang
26.01.2023
Impfdatum
26.01.2023
Beginn
26.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site swelling

Symptomtext

Patient received 12 month vaccines. Had patient wait 10-15 mins after vaccines were given. Checked patient at 10:40, and noticed patient had redness and slight swelling on right thigh where Varicella vaccine was administered. Called primary provider to get a second look and opinion on thigh. Provider prescribed Benadryl for mild reaction to Varicella vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
NKA
Vorherige Impfungen
-

VAERS 2568604

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039948

gering
Staat
CA
Alter
1,1
Geschlecht
F
Eingang
26.01.2023
Impfdatum
25.01.2023
Beginn
25.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Swelling

Symptomtext

Patient had slight swelling and redness. Was given 2.5mL of12.5mg/5mL of Benadryl P.O x1 in office. Lot: 1HK0857 EXP: 06/2023

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
NKA
Vorherige Impfungen
-

VAERS 2427927

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039948

gering
Staat
UT
Alter
53,0
Geschlecht
F
Eingang
02.09.2022
Impfdatum
02.09.2022
Beginn
02.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

VACCINE ADMINISTRATION ERROR. CLIENT WAS TO RECEIVE AN MMR AND A VARICELLA. NURSE INADVERENTLY ADMINISTERED A VARICELLA IN THE RIGHT ARM AND A PROQUAD (IWHEN IT SHOULD HAVE BEEN A MMR) IN THE LEFT ARM. THUS THE CLIENT HAS HAD TWO DOSES OF VARICELLA TODAY. NO KNOWN ADVERSE AFFECT AT THIS TIME.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
DIABETES MELLITUS
Andere Medikamente
UNKNOWN
Allergien
NO KNOWN ALLERGIES
Vorherige Impfungen
-

VAERS 2412983

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039948

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
17.08.2022
Impfdatum
08.08.2022
Beginn
08.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

no adverse event; Caller is vaccine coordinator reporting administered doses of improperly stored VARIVAX; This spontaneous report was received from a vaccine coordinator and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On an unspecified date, doses of varicella virus vaccine live (oka/merck) (VARIVAX) Lot #U039948, expiration date: 16-DEC-2023, underwent a temperature excursion of 6 to 14 fahrenheit degree for 6 hours and 15 minutes, and from 14 to 46 fahrenheit degree during 1 hour and 30 minutes, with no previous temperature excursions. On 08-AUG-2022, the patient was vaccinated with one dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot #U039948, expiration date: 16-DEC-2023(strength, dosage regimen, anatomical location, and route of administration were not provided), administered for prophylaxis (Product storage error). No adverse event was reported. This is one of the several cases reported by the same reporter.; Sender's Comments: US-009507513-2208USA004548:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2412982

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039948

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
17.08.2022
Impfdatum
08.08.2022
Beginn
08.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional adverse events; administered doses of improperly stored VARIVAX; This spontaneous report was received from a vaccine coordinator and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 08-AUG-2022, the patient was vaccinated with 1 dose of an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U039948, expiration date: 16-DEC-2023, administered for prophylaxis (strength, and route of administration were not provided) (product storage error). The vaccine was stored at a temperature between 6 to 14 Fahrenheit degrees (F) for 6 hours and 15 minutes, and between 14 F to 46 F (15.2 F) for 1 hour and 30 minutes. There was no other previous temperature excursion. No additional adverse events were reported.; Sender's Comments: US-009507513-2208USA004566:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2365777

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039948

gering
Staat
VA
Alter
-
Geschlecht
U
Eingang
12.07.2022
Impfdatum
14.06.2022
Beginn
14.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no other AE occurred; VARIVAX was administered after a temperature excursion; This spontaneous report was received from a medical assistant and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 14-JUN-2022, the patient was vaccinated with improperly stored vaccine of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection (dose: 1 dose, lot #: U039948, expiration date: 16-DEC-2023; route and strength were unknown) for prophylaxis (Product storage error). The vaccine underwent temperature excursion of -2.5 Celsius for 5 hours and 6 minutes. There was no previous temperature excursion. No other adverse event (AE) occurred. This is one of several reports received from same reporter.; Sender's Comments: US-009507513-2206USA005711: US-009507513-2206USA005697: US-009507513-2206USA005588: US-009507513-2206USA005579:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2359152

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039948

gering
Staat
VA
Alter
-
Geschlecht
U
Eingang
06.07.2022
Impfdatum
15.06.2022
Beginn
15.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AE; Customer reported VARIVAX was administered after a temperature excursion.; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, past drug reactions or allergies, and concomitant therapies were not reported. On 15-JUN-2022, the patient was vaccinated with one (1) improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) (strength, vaccination scheme frequency, route of administration, and anatomical site of application were provided; lot # U039948 that has been verified to be a valid lot number with expiration date reported and established as 16-DEC-2023) for prophylaxis. The administered vaccine experienced the temperature excursion of minus (-) 2.5 degrees Celsius (C) for a timeframe of 5 hours and 6 minutes. There was no previous temperature excursion. No other adverse event (AE) occurred (no adverse event). This is one of five reports received from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2334818

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u039948

gering
Staat
VA
Alter
-
Geschlecht
U
Eingang
25.06.2022
Impfdatum
13.06.2022
Beginn
13.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no other AE occurred; VARIVAX was administered after a temperature excursion; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 13-JUN-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX), 1 dose, lot #u039948, expiration date: 16-DEC-2023 (route of administration was not provided). The administered dose of vaccine experienced the temperature excursion of -2.5 degrees Celsius for 5 hours and 6 minutes. There was no previous temperature excursion. No other adverse event (AE) occurred. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA005579: US-009507513-2206USA005697: US-009507513-2206USA005817: US-009507513-2206USA005711:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2334817

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u039948

gering
Staat
VA
Alter
-
Geschlecht
U
Eingang
25.06.2022
Impfdatum
13.06.2022
Beginn
13.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

no other AE occurred; VARIVAX was administered after a temperature excursion; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 13-JUN-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX), 1 dose, lot #u039948, expiration date: 16-DEC-2023 (route of administration was not provided). The administered dose of vaccine experienced the temperature excursion of -2.5 degrees Celsius for 5 hours and 6 minutes. There was no previous temperature excursion. No other adverse event (AE) occurred. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA005588: US-009507513-2206USA005697: US-009507513-2206USA005817: US-009507513-2206USA005711:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2326546

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039948

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
22.06.2022
Impfdatum
31.05.2022
Beginn
31.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; one dose of VARIVAX was given following a temperature excursion; This spontaneous report has been received from an office vaccine coordinator, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant medication was not provided. On 31-MAY-2022, the patient was vaccinated with one dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # U039948 with expiration date: 16-DEC-2023, single dose, strength and route were unknown) for prophylaxis (product storage error) and sterile diluent (indication, dose, frequency, strength, route, lot number and expiration date were unknown), both following a temperature excursion. No other adverse event/no product quality complaints (PQC). Administered dose of varicella virus vaccine live (oka/merck)(VARIVAX) experienced the temperature excursion below 18.7 Fahrenheit degrees (F) for 3 hours 15 minutes 0 seconds. No previous temperature excursions reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2314140

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039948

gering
Staat
MI
Alter
11,0
Geschlecht
M
Eingang
09.06.2022
Impfdatum
07.06.2022
Beginn
07.06.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration

Symptomtext

Varicella vaccine was given 14 days after MMR vaccine was administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
no tests, no concerns
Aktuelle Erkrankungen
None
Vorgeschichte
none
Andere Medikamente
NA
Allergien
No allergies reported
Vorherige Impfungen
-

VAERS 2314134

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039948

gering
Staat
MI
Alter
14,0
Geschlecht
M
Eingang
09.06.2022
Impfdatum
07.06.2022
Beginn
07.06.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration

Symptomtext

Varicella vaccine was given 14 days after MMR vaccine was administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
No tests, no concerns
Aktuelle Erkrankungen
No illness, no concerns
Vorgeschichte
None
Andere Medikamente
NA
Allergien
No reported allergies
Vorherige Impfungen
-